Log 1 C 0 71 log P 1

  • Slides: 29
Download presentation

Αιμοσφαιρίνη Log 1/ C = 0. 71 log P + 1. 51, n =

Αιμοσφαιρίνη Log 1/ C = 0. 71 log P + 1. 51, n = 17, r 2 = 0. 902, s = 0. 160

Τρανσφεράσες Log Krel = 0. 21 log P - 0. 33 - - 0.

Τρανσφεράσες Log Krel = 0. 21 log P - 0. 33 - - 0. 31, n = 6, r 2 = 0. 992, s = 0. 043

παπαϊνη Log 1 /Km = 7. 73 F + 0. 56 MR 4 +

παπαϊνη Log 1 /Km = 7. 73 F + 0. 56 MR 4 + 1. 14 3 ‘ + 2. 00, n = 37, r 2 = 0. 872, s = 0. 383

Λυάσες Lοg 1/Ki = 0. 80 + 0. 27 log P + 0. 33,

Λυάσες Lοg 1/Ki = 0. 80 + 0. 27 log P + 0. 33, n = 16, r 2 = 0. 937, s = 0. 168

DHFR Dihydrofolic reductase Log 1/Ki = 1. 24 MR’ 4 + 0. 52 MR’

DHFR Dihydrofolic reductase Log 1/Ki = 1. 24 MR’ 4 + 0. 52 MR’ 3 + 0. 42 MR 5 – 0. 13 MR 5 2 + 0. 46 4 + 0. 31 3’ – 0. 92 log (β 4. 10 4 + 1) – 0. 71 log (β 3. 10 3’ + 1) + 5. 45 N = 65, r 2 = 0. 799, s = 0. 245, 4 opt. = 0. 49, 3’ opt. = 1. 3, MR 5 opt. = 1. 66

Υδροξυαιθυλαμινομεθυλ-4Η-χρωμεν-4 -όνες Από τη μελέτη QSAR [Joo et al. 2012] προέκυψε η εξίσωση: log

Υδροξυαιθυλαμινομεθυλ-4Η-χρωμεν-4 -όνες Από τη μελέτη QSAR [Joo et al. 2012] προέκυψε η εξίσωση: log 1/IC 50=0. 825(0. 396)B 1 R+0. 078(0. 035)B 5 -R+3. 188(0. 718) n=10, r =0. 917, r 2=0. 841, q 2=0. 689, s=0. 075, F 2, 7=18. 287, α= 0. 01 B 1 vs B 5= 0. 157; clog P vs B 1 = 0. 243; clog P vs B 5 =0. 140

novel tubulin polymerization inhibitors bearing a 1, 3, 4 -thiadiazole skeleton and a cinnamoyl-amide,

novel tubulin polymerization inhibitors bearing a 1, 3, 4 -thiadiazole skeleton and a cinnamoyl-amide, based on molecular hybridization Log (1/IC 50) = -0. 335(0. 073) B 1 -R 1 + 0. 194(0. 036) B 5 -R 1 + 0. 099(0. 032) B 5 -R 2 - 0. 355(0. 085) σp (R 2) + 5. 281 (0. 135) n = 24 r = 0. 970 r 2 = 0. 942 q 2 = 0. 898 s = 0. 055 Q = 17. 64 F 1, 22 = 7. 91, α = 0. 10 F 1, 21 = 17. 31, α = 0. 01 F 1, 20 = 22. 53, α = 0. 01 F 1, 19 = 43. 24, α = 0. 01 F 4, 19 = 72. 80 α = 0. 01 B 1 -R 1 vs B 5 -R 1= 0. 062 , B 1 -R 1 vs B 5 -R 2 = 0. 002, B 1 -R 1 vs σp(R 2)= 0. 001 B 5 R 2 vs σp(R 2)= 0. 003, B 5 -R 2 vs B 5 -R 1 = 0. 000 C log P vs B 1 -R 1 = 0. 462 , C log P vs B 5 -R 1= 0. 001 C log P vs B 5 -R 2 =0. 042, C log P vs σp(R 2) = 0. 298

The model underlines the important role of steric factors for antitubulin activity. B 1

The model underlines the important role of steric factors for antitubulin activity. B 1 -R 1, B 5 -R 1 and B 5 -R 2 are Verloop’s sterimol parameters for the minimum and maximum width, for the R 1 and R 2 substituents respectively. The most significant variable is B 5 for R 1 phenyl substituents, followed by B 1 R 1, σp (R 2) and B 5 -R 2. Enhancement of the maximum width for R 1 and R 2 leads to an increase of inhibition. The negative sign with B 1 -R 1 denotes a decrease in biological response. The Hammett’s σp stands for the electronic effect of R 2 - phenyl substituents of cinnamic scaffold and follows the steric parameters. Negative coefficient suggests that electron-donating π-groups may enhance the inhibitory activity

No role for lipophilicity was defined. Compound 10 is omitted. Compound 10 is the

No role for lipophilicity was defined. Compound 10 is omitted. Compound 10 is the only representative with a combination of Cl/OMe substituents. It shows the largest deviation between experimental and calculated values Δ Log (1/IC 50) = 0. 18, in comparison within the data set. No interrelationship between the used variables was found.